Literature DB >> 8479798

Aerobic resistance of Trichomonas vaginalis to metronidazole induced in vitro.

J Tachezy1, J Kulda, E Tomková.   

Abstract

Aerobic resistance of Trichomonas vaginalis to metronidazole was induced in vitro by anaerobic cultivation of drug-susceptible trichomonads with low concentrations of the drug (2-3 micrograms/ml) for 50 days. Minimal lethal concentrations (MLC) for metronidazole of the resistant derivatives were high in aerobic susceptibility assays (MLC = 216-261.5 micrograms/ml) but low in anaerobic assays (MLC = 4.2-6.3 micrograms/ml), surpassing MLC values of their parent strain approximately 50-fold and 3-fold under aerobiosis and anaerobiosis, respectively. Sensitivity to metronidazole under anaerobic conditions and activity of the hydrogenosomal enzyme pyruvate: ferredoxin oxidoreductase indicated that the resistance was of the aerobic type. Dependence of the resistance manifestation on O2 was further confirmed by susceptibility assays in vitro performed in defined gas mixtures of different oxygen content (1-20%). Five percent concentration of O2 proved to be the threshold required for resistance demonstration and the MLC values further increased with increasing O2 concentrations. The in vitro-induced resistance was also demonstrated in vivo by subcutaneous mouse assay. The dose of metronidazole needed to cure 50% of infected mice (DC50) was 223 mg/kg x 3 for resistant derivative MR-3a but 6.6 mg/kg x 3 only for its drug-susceptible parent strain. The metronidazole-resistant strains developed in this study correspond by their properties to drug-resistant T. vaginalis strains isolated from patients refractory to treatment, and promise to be a useful tool in the study of 5-nitroimidazole aerobic resistance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8479798     DOI: 10.1017/s0031182000074783

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  9 in total

1.  Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.

Authors:  T Meri; T S Jokiranta; L Suhonen; S Meri
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Biochemistry and evolution of anaerobic energy metabolism in eukaryotes.

Authors:  Miklós Müller; Marek Mentel; Jaap J van Hellemond; Katrin Henze; Christian Woehle; Sven B Gould; Re-Young Yu; Mark van der Giezen; Aloysius G M Tielens; William F Martin
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 3.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis.

Authors:  Keonte J Graves; Jan Novak; W Evan Secor; Patricia J Kissinger; Jane R Schwebke; Christina A Muzny
Journal:  Parasitology       Date:  2020-07-30       Impact factor: 3.234

Review 5.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Down-regulation of flavin reductase and alcohol dehydrogenase-1 (ADH1) in metronidazole-resistant isolates of Trichomonas vaginalis.

Authors:  David Leitsch; Mirjana Drinić; Daniel Kolarich; Michael Duchêne
Journal:  Mol Biochem Parasitol       Date:  2012-03-17       Impact factor: 1.759

7.  Concordance between genetic relatedness and phenotypic similarities of Trichomonas vaginalis strains.

Authors:  V Hampl; S Vanácová; J Kulda; J Flegr
Journal:  BMC Evol Biol       Date:  2001-11-15       Impact factor: 3.260

8.  CRISPR/Cas9-mediated gene modification and gene knock out in the human-infective parasite Trichomonas vaginalis.

Authors:  Brian D Janssen; Yi-Pei Chen; Brenda M Molgora; Shuqi E Wang; Augusto Simoes-Barbosa; Patricia J Johnson
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

9.  Physiological aspects of nitro drug resistance in Giardia lamblia.

Authors:  Joachim Müller; Andrew Hemphill; Norbert Müller
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-04-28       Impact factor: 4.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.